TIMP1 and acute kidney injury: Recent trials have demonstrated that combining early biomarker-based risk stratification, such as TIMP-2×IGFBP7, with structured KDIGO care bundles reduces AKI severity and has been associated with lower rates of MAKE-30 outcomes, dialysis, and mortality in high-risk surgical patients [28,29].